首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Chemically Oversulfated Glycosaminoglycans Are Potent Modulators of Contact System Activation and Different Cell Signaling Pathways
Authors:Jing Pan  Yi Qian  Xiaodong Zhou  Hong Lu  Eduardo Ramacciotti  Lijuan Zhang
Institution:From the Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110.;the §Department of Pathology, Loyola University Medical Center, Maywood, Illinois 60153, and ;Jobst Vascular Surgery Research Laboratory, Section of Vascular Surgery, Cardiovascular Center, University of Michigan, Ann Arbor, Michigan 48109
Abstract:Contaminated heparin was associated with adverse reactions by activating the contact system. Chemically oversulfated/modified glycosaminoglycans (GAGs) consisting of heparan sulfate, dermatan sulfate, and chondroitin sulfate have been identified as heparin contaminants. Current studies demonstrated that each component of oversulfated GAGs was comparable with oversulfated chondroitin sulfate in activating the contact system. By testing a series of unrelated negatively charged compounds, we found that the contact system recognized negative charges rather than specific chemical structures. We further tested how oversulfated GAGs and contaminated heparins affect different cell signaling pathways. Our data showed that chemically oversulfated GAGs and contaminated heparin had higher activity than the parent compounds and authentic heparin, indicative of sulfation-dominant and GAG sequence-dependent activities in BaF cell-based models of fibroblast growth factor/fibroblast growth factor receptor, glial cell line-derived neurotrophic factor/c-Ret, and hepatocyte growth factor/c-Met signaling. In summary, these data indicate that contaminated heparins intended for blood anticoagulation not only activated the contact system but also modified different GAG-dependent cell signaling pathways.
Keywords:Blood Coagulation/Kallikrein  Blood Coagulation/Thrombin  Cell/Mitogens  Extracellular Matrix/Glycosaminoglycans  Receptors  FGF  GDNF  HGF
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号